Central pontine myelinolysis screening: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Central pontine myelinolysis}} {{CMG}}; {{AE}} {{MMJ}} ==Overview== ==Screening== There is insufficient evidence to recommend routine screening for [disease/mal..." |
|||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for Central pontine myelinolysis. | |||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for | There is insufficient evidence to recommend routine screening for Central pontine myelinolysis. | ||
==References== | ==References== | ||
Revision as of 08:10, 2 November 2019
|
Central pontine myelinolysis Microchapters |
|
Differentiating Central pontine myelinolysis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Central pontine myelinolysis screening On the Web |
|
American Roentgen Ray Society Images of Central pontine myelinolysis screening |
|
Risk calculators and risk factors for Central pontine myelinolysis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
There is insufficient evidence to recommend routine screening for Central pontine myelinolysis.
Screening
There is insufficient evidence to recommend routine screening for Central pontine myelinolysis.